{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:7097402",
      "entity_text" : "PCa",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:6013",
      "entity_text" : "testosterone",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "For more than 70 years, the contention that high levels of testosterone or that the use of testosterone therapy (TTh) increases the development and progression of prostate cancer (PCa) has been widely accepted and practiced.",
  "reading_complete" : "2020-08-04T12:39:19Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:35:23Z",
  "trigger" : "increases",
  "evidence" : [ "testosterone therapy (TTh) increases the development and progression of prostate cancer (PCa" ],
  "pmc_id" : "5503974",
  "score" : 0
}